Article
Omicron N501Y mutation among SARS-CoV-2 lineages: Insilico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine.
Travel medicine and infectious disease - 1 Jan 2000
Kazybay Bexultan, Ahmad Ashfaq, Mu Chenglin, Mengdesh Diana, Xie Yingqiu
Abstract excerpt
Variants of SARS-CoV-2 lineages including the most recently circulated Omicron, and previous pandemic B.1.351, B.1.1.7, which have been public concerns, contain a N501Y mutation located in the spike receptor binding domain. However, the potential interactions with host cells linking N501Y mutation to pathogenic relevance remain elusive. Recently, we and others report that kinases such as PI3K/AKT signaling are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
